These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 38755688)

  • 1. RECOVER-NEURO: study protocol for a multi-center, multi-arm, phase 2, randomized, active comparator trial evaluating three interventions for cognitive dysfunction in post-acute sequelae of SARS-CoV-2 infection (PASC).
    Knopman DS; Laskowitz DT; Koltai DC; Charvet LE; Becker JH; Federman AD; Wisnivesky J; Mahncke H; Van Vleet TM; Bateman L; Kim DY; O'Steen A; James M; Silverstein A; Lokhnygina Y; Rich J; Feger BJ; Zimmerman KO
    Trials; 2024 May; 25(1):326. PubMed ID: 38755688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC).
    Santana K; França E; Sato J; Silva A; Queiroz M; de Farias J; Rodrigues D; Souza I; Ribeiro V; Caparelli-Dáquer E; Teixeira AL; Charvet L; Datta A; Bikson M; Andrade S
    Brain Stimul; 2023; 16(1):100-107. PubMed ID: 36693536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol.
    Kuut TA; Müller F; Aldenkamp A; Assmann-Schuilwerve E; Braamse A; Geerlings SE; Gibney KB; Kanaan RAA; Nieuwkerk P; Olde Hartman TC; Pauëlsen D; Prins M; Slieker K; Van Vugt M; Bleeker-Rovers CP; Keijmel SP; Knoop H
    Trials; 2021 Dec; 22(1):867. PubMed ID: 34857010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving cognition in severe mental illness by combining cognitive remediation and transcranial direct current stimulation: study protocol for a pragmatic randomized controlled pilot trial (HEADDSET).
    Poppe A; Bais L; van Duin D; Ćurčić-Blake B; Pijnenborg GHM; van der Meer L
    Trials; 2021 Apr; 22(1):275. PubMed ID: 33849658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
    Halford S; Wan S; Dragoni I; Silvester J; Nazarov B; Anthony D; Anthony S; Ladds E; Norrie J; Dhaliwal K;
    Trials; 2021 Aug; 22(1):550. PubMed ID: 34412682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial.
    Geng LN; Bonilla H; Hedlin H; Jacobson KB; Tian L; Jagannathan P; Yang PC; Subramanian AK; Liang JW; Shen S; Deng Y; Shaw BJ; Botzheim B; Desai M; Pathak D; Jazayeri Y; Thai D; O'Donnell A; Mohaptra S; Leang Z; Reynolds GZM; Brooks EF; Bhatt AS; Shafer RW; Miglis MG; Quach T; Tiwari A; Banerjee A; Lopez RN; De Jesus M; Charnas LR; Utz PJ; Singh U
    JAMA Intern Med; 2024 Sep; 184(9):1024-1034. PubMed ID: 38848477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
    Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
    Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-managing symptoms of Long COVID: an education and strategies research protocol.
    Rybkina J; Jacob N; Colella B; Gold D; Stewart DE; Ruttan LA; Meusel LC; McAndrews MP; Abbey S; Green R
    Front Public Health; 2024; 12():1106578. PubMed ID: 38384879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design.
    Horwitz LI; Thaweethai T; Brosnahan SB; Cicek MS; Fitzgerald ML; Goldman JD; Hess R; Hodder SL; Jacoby VL; Jordan MR; Krishnan JA; Laiyemo AO; Metz TD; Nichols L; Patzer RE; Sekar A; Singer NG; Stiles LE; Taylor BS; Ahmed S; Algren HA; Anglin K; Aponte-Soto L; Ashktorab H; Bassett IV; Bedi B; Bhadelia N; Bime C; Bind MC; Black LJ; Blomkalns AL; Brim H; Castro M; Chan J; Charney AW; Chen BK; Chen LQ; Chen P; Chestek D; Chibnik LB; Chow DC; Chu HY; Clifton RG; Collins S; Costantine MM; Cribbs SK; Deeks SG; Dickinson JD; Donohue SE; Durstenfeld MS; Emery IF; Erlandson KM; Facelli JC; Farah-Abraham R; Finn AV; Fischer MS; Flaherman VJ; Fleurimont J; Fonseca V; Gallagher EJ; Gander JC; Gennaro ML; Gibson KS; Go M; Goodman SN; Granger JP; Greenway FL; Hafner JW; Han JE; Harkins MS; Hauser KSP; Heath JR; Hernandez CR; Ho O; Hoffman MK; Hoover SE; Horowitz CR; Hsu H; Hsue PY; Hughes BL; Jagannathan P; James JA; John J; Jolley S; Judd SE; Juskowich JJ; Kanjilal DG; Karlson EW; Katz SD; Kelly JD; Kelly SW; Kim AY; Kirwan JP; Knox KS; Kumar A; Lamendola-Essel MF; Lanca M; Lee-Lannotti JK; Lefebvre RC; Levy BD; Lin JY; Logarbo BP; Logue JK; Longo MT; Luciano CA; Lutrick K; Malakooti SK; Mallett G; Maranga G; Marathe JG; Marconi VC; Marshall GD; Martin CF; Martin JN; May HT; McComsey GA; McDonald D; Mendez-Figueroa H; Miele L; Mittleman MA; Mohandas S; Mouchati C; Mullington JM; Nadkarni GN; Nahin ER; Neuman RB; Newman LT; Nguyen A; Nikolich JZ; Ofotokun I; Ogbogu PU; Palatnik A; Palomares KTS; Parimon T; Parry S; Parthasarathy S; Patterson TF; Pearman A; Peluso MJ; Pemu P; Pettker CM; Plunkett BA; Pogreba-Brown K; Poppas A; Porterfield JZ; Quigley JG; Quinn DK; Raissy H; Rebello CJ; Reddy UM; Reece R; Reeder HT; Rischard FP; Rosas JM; Rosen CJ; Rouphael NG; Rouse DJ; Ruff AM; Saint Jean C; Sandoval GJ; Santana JL; Schlater SM; Sciurba FC; Selvaggi C; Seshadri S; Sesso HD; Shah DP; Shemesh E; Sherif ZA; Shinnick DJ; Simhan HN; Singh U; Sowles A; Subbian V; Sun J; Suthar MS; Teunis LJ; Thorp JM; Ticotsky A; Tita ATN; Tragus R; Tuttle KR; Urdaneta AE; Utz PJ; VanWagoner TM; Vasey A; Vernon SD; Vidal C; Walker T; Ward HD; Warren DE; Weeks RM; Weiner SJ; Weyer JC; Wheeler JL; Whiteheart SW; Wiley Z; Williams NJ; Wisnivesky JP; Wood JC; Yee LM; Young NM; Zisis SN; Foulkes AS
    PLoS One; 2023; 18(6):e0286297. PubMed ID: 37352211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromodulation through brain stimulation-assisted cognitive training in patients with post-COVID-19 cognitive impairment (Neuromod-COV): study protocol for a PROBE phase IIb trial.
    Thams F; Antonenko D; Fleischmann R; Meinzer M; Grittner U; Schmidt S; Brakemeier EL; Steinmetz A; Flöel A
    BMJ Open; 2022 Apr; 12(4):e055038. PubMed ID: 35410927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective non-randomized controlled trial testing the effectiveness of psychotherapeutic inpatient treatment of Post-COVID-19 syndrome - study protocol.
    Koller K; Kastel-Hoffmann S; Herold R; Morawa E; Lieb M; Krehbiel J; Hohberger B; Erim Y
    BMC Psychol; 2024 Sep; 12(1):486. PubMed ID: 39285491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and auditory biomarker analysis of fronto-temporal transcranial direct current stimulation (tDCS) in targeting cognitive impairment associated with recent-onset schizophrenia: study protocol for a multicenter randomized double-blind sham-controlled trial.
    Dondé C; Bastin J; Pouchon A; Costes N; Fakra E; Galvão F; Gay A; Haesebaert F; Lamalle L; Mérida I; Rigon M; Schneider F; Troprès I; Brunelin J; Polosan M
    Trials; 2023 Feb; 24(1):141. PubMed ID: 36829240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.
    Hanson BA; Visvabharathy L; Ali ST; Kang AK; Patel TR; Clark JR; Lim PH; Orban ZS; Hwang SS; Mattoon D; Batra A; Liotta EM; Koralnik IJ
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35256481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.